<!doctype html><html lang=en><head><meta name=generator content="Hugo 0.79.0"><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta property="og:title" content="FDA officials are off on a three-week sprint to review J&J COVID-19 vaccine data"><meta name=author content="The Verge"><meta name=keywords content="The-Verge"><meta property="og:title" content="FDA officials are off on a three-week sprint to review J&J COVID-19 vaccine data"><meta property="og:description" content="Johnson & Johnson released data from its vaccine clinical trial last week.  Johnson & Johnson announced yesterday that it had officially asked the Food and Drug Administration to authorize its COVID-19 vaccine, kicking off a process that will send its one-shot immunization through a gauntlet of analysts and experts. If all goes as expected and the agency agrees that the benefits of the vaccine outweigh the risks, the United States could have a third shot available by the end of February."><meta property="og:type" content="article"><meta property="og:url" content="https://news.panz3r.dev/post/9e6967ebe8c611f51a318168dd5888212348739c8a87ea243120c97b7f480fc1/"><meta property="article:published_time" content="2021-02-05T15:44:32+00:00"><meta property="article:modified_time" content="2021-02-05T15:44:32+00:00"><meta name=twitter:card content="summary"><meta name=twitter:title content="FDA officials are off on a three-week sprint to review J&J COVID-19 vaccine data"><meta name=twitter:description content="Johnson & Johnson released data from its vaccine clinical trial last week.  Johnson & Johnson announced yesterday that it had officially asked the Food and Drug Administration to authorize its COVID-19 vaccine, kicking off a process that will send its one-shot immunization through a gauntlet of analysts and experts. If all goes as expected and the agency agrees that the benefits of the vaccine outweigh the risks, the United States could have a third shot available by the end of February."><link rel="shortcut icon" href=/favicon.ico><link rel=apple-touch-icon sizes=180x180 href=/apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=/favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=/favicon-16x16.png><link rel=mask-icon color=#8a0000 href=/safari-pinned-tab.svg><meta name=msapplication-TileColor content="#8A0000"><link rel=stylesheet type=text/css media=screen href=/css/normalize.min.15dd2454cf02be612cd84be5a0307ecae7e9c84d08f88ab2d1e9332717d10fe9b63484bb4c5352072da0915d1a6d48fa41994fb99c120c891cca431b4448f44d.css integrity="sha512-Fd0kVM8CvmEs2EvloDB+yufpyE0I+Iqy0ekzJxfRD+m2NIS7TFNSBy2gkV0abUj6QZlPuZwSDIkcykMbREj0TQ=="><link rel=stylesheet type=text/css media=screen href=/css/main.min.213824d03b199f0409b76c8566e3f3e4fbbe8f03c184b43a665128ee2120bbf3704a1d62249e92ad27ba4c158e21f02299e52148b06efa51a5e54824bfdf6f95.css integrity="sha512-ITgk0DsZnwQJt2yFZuPz5Pu+jwPBhLQ6ZlEo7iEgu/NwSh1iJJ6SrSe6TBWOIfAimeUhSLBu+lGl5Ugkv99vlQ=="><link rel=stylesheet type=text/css media=screen href=/css/all.min.110b9b90a76992e589133569a74d7933787d3b97d05cb148bac6c44edaa09afb226b6bd200c52f9efbe30eaecffc11b244d8ed8109b46bb490cd09109656509c.css integrity="sha512-EQubkKdpkuWJEzVpp015M3h9O5fQXLFIusbETtqgmvsia2vSAMUvnvvjDq7P/BGyRNjtgQm0a7SQzQkQllZQnA=="><title>FDA officials are off on a three-week sprint to review J&J COVID-19 vaccine data | Panz3r News</title></head><body><header><div id=titletext><h2 id=title><a href=https://news.panz3r.dev/>Panz3r News</a></h2></div><div id=title-description><div id=social><nav><ul><li><a href=https://github.com/panz3r/news-feed><i title=Github class="icons fab fa-github"></i></a></li><li><a href=/index.xml><i title=RSS class="icons fas fa-rss"></i></a></li></ul></nav></div></div><div id=mainmenu><nav><ul><li><a href=/>Home</a></li><li><a href=/tags>Tags</a></li></ul></nav></div></header><main><div class=post><div class=author><p>From <a href=https://www.theverge.com/2021/2/5/22267984/covid-vaccine-johnson-fda-one-dose-review target=_blank rel="noopener noreferrer">The Verge</a></p></div><div class=post-header><div class=meta><div class=date><span class=day>05</span>
<span class=rest>Feb 2021</span></div></div><div class=matter><h1 class=title>FDA officials are off on a three-week sprint to review J&J COVID-19 vaccine data</h1></div></div><div class=markdown><figure><img alt="Clinical Trial of Johnson & Johnson Covid-19 Vaccine" src="https://cdn.vox-cdn.com/thumbor/hIAI65Pc3swF32a54MhFMqMbkMA=/0x1:3726x2485/1310x873/cdn.vox-cdn.com/uploads/chorus_image/image/68774951/1230177145.0.jpg"><figcaption><em>Johnson & Johnson released data from its vaccine clinical trial last week.</em></figcaption></figure><p id=kHoCXO>Johnson & Johnson announced yesterday that it had <a href=https://www.prnewswire.com/news-releases/johnson--johnson-announces-submission-of-application-to-the-us-fda-for-emergency-use-authorization-of-its-investigational-single-shot-janssen-covid-19-vaccine-candidate-301222768.html>officially asked</a> the Food and Drug Administration to authorize its COVID-19 vaccine, kicking off a process that will send its one-shot immunization through a gauntlet of analysts and experts.</p><p id=aggyoZ>If all goes as expected and the agency agrees that the benefits of the vaccine outweigh the risks, the United States could have a third shot available by the end of February. Experts <a href="https://go.redirectingat.com?id=66960X1514734&xs=1&url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-021-00119-7&referrer=theverge.com&sref=https%3A%2F%2Fwww.theverge.com%2F2021%2F2%2F5%2F22267984%2Fcovid-vaccine-johnson-fda-one-dose-review#donotlink" rel="sponsored nofollow noopener" target=_blank>hope</a> that this vaccine — which only takes one dose and can be stored in the refrigerator — could accelerate the United States’ vaccination campaign.</p><p id=esfKy5>Over the next few weeks, FDA officials will work at breakneck speeds to review the data submitted by Johnson & Johnson. Then, they’ll write up a report and submit it to...</p><p><a href=https://www.theverge.com/2021/2/5/22267984/covid-vaccine-johnson-fda-one-dose-review>Continue reading…</a></p></div><div class=tags><div class=taxosfloating_left><p>Tags</p></div><div class=termsfloating_right><p><a href=/tags/the-verge/>the-verge</a></p></div><div class=clearit></div></div></div></main><footer><a href=https://github.com/panz3r>Panz3r</a> 2020 | <a href=https://github.com/panz3r/hugo-vitae>Vitae</a> theme for <a href=https://gohugo.io>Hugo</a></footer></body></html>